XUNCE(03317): Partial exercise of excess rights issue, price stabilization action and end of price stabilization period.
Junze (03317) announces that the sponsor and overall coordinator (representing itself and international underwriters) partially exercised the oversubscription rights as stated in the prospectus on January 22, 2026 (Thursday), involving a total of 194,400 H shares, accounting for approximately 0.86% of the total number of shares available for subscription under the preliminary global offering before the exercise of oversubscription rights. The oversubscribed shares (defined below) will be issued and distributed by the Company at a price of HK $48.00 per H share (i.e. the offering price per H share under the global offering, excluding 1.0% brokerage commission, 0.0027% Securities and Futures Commission trading fee, 0.00015% Stock Exchange trading fee and 0.00565% Stock Exchange trading fee).
XUNCE (03317) announced that the sponsor and overall coordinator (acting for itself and on behalf of international underwriters) partially exercised the oversubscription rights as stated in the prospectus on January 22, 2026 (Thursday). This involved a total of 194,400 H shares, representing approximately 0.86% of the initial offering of H shares available for subscription before the exercise of oversubscription rights. The oversubscribed shares (as defined below) will be issued and distributed by the company at a price of HK$48.00 per H share (i.e., the offer price per H share under the global offering, excluding 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% Hong Kong Monetary Authority transaction levy and 0.00565% HKEx trading fee).
In accordance with section 9(2) of the Securities and Futures (Price Stabilization) Rules under Chapter 571W of the Laws of Hong Kong, the company announced that the stabilization period for the global offering ended on January 22, 2026 (Thursday) (i.e., the 30th day after the deadline for submitting the Hong Kong public offering application). The stabilizing price manager, Guotai Junan Securities (Hong Kong) Limited or any affiliated person acting on its behalf, disclosed the stabilizing actions taken during the stabilization period as follows:
(i) In the international offering, a total of 3,375,000 H shares were oversubscribed, representing approximately 15.0% of the initial offering of H shares available for subscription before the exercise of oversubscription rights;
(ii) During the stabilization period, a total of 3,261,400 H shares were continuously purchased in the market at prices ranging from HK$38.02 to HK$48.00 per H share (excluding 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% Hong Kong Monetary Authority transaction levy and 0.00565% HKEx trading fee), representing approximately 14.50% of the initial offering of H shares available for subscription before the exercise of oversubscription rights. The last purchase made by the stabilizing price manager or any affiliated person acting on its behalf in the market during the stabilization period was on January 12, 2026 (Monday) at a price of HK$48.00 per H share (excluding fees mentioned above);
(iii) During the stabilization period, a total of 808,000 H shares were continuously sold in the market at prices ranging from HK$62.60 to HK$72.00 per H share (excluding fees mentioned above), representing approximately 0.36% of the initial offering of H shares available for subscription before the exercise of oversubscription rights. The last sale made by the stabilizing price manager or any affiliated person acting on its behalf in the market during the stabilization period was on January 20, 2026 (Tuesday) at a price of HK$64.91 per H share (excluding fees mentioned above); and
(iv) The sponsor and overall coordinator (acting for itself and on behalf of international underwriters) partially exercised the oversubscription rights on January 22, 2026 (Thursday) at a price of HK$48.00 per H share (i.e., the offer price per H share under the global offering, excluding fees mentioned above), involving a total of 194,400 H shares, representing approximately 0.86% of the initial offering of H shares available for subscription before the exercise of oversubscription rights, to facilitate the delivery of some H shares to the allotted subscribers who have agreed to delay delivery of their subscribed H shares under the global offering.
The oversubscription rights that the sponsor and overall coordinator (acting for itself and on behalf of international underwriters) have not yet exercised expired on January 22, 2026 (Thursday).
Related Articles

INSILICO (03696): AI-driven NLRP3 inhibitor ISM8969 clinical trial application approved by FDA Has "best-in-class" potential
.png)
Hydsoft Technology (301316.SZ) issued shares to purchase assets and raised funds for matching, the application documents have been accepted by the Shenzhen Stock Exchange.

Zhongjin: European and American trade relations under geopolitical disputes.
INSILICO (03696): AI-driven NLRP3 inhibitor ISM8969 clinical trial application approved by FDA Has "best-in-class" potential

Hydsoft Technology (301316.SZ) issued shares to purchase assets and raised funds for matching, the application documents have been accepted by the Shenzhen Stock Exchange.
.png)
Zhongjin: European and American trade relations under geopolitical disputes.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


